NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
Recode Studios

Recode Studios

IPO
Issue: 44.59 CrPrice: ₹ 150.00
View Details

Recode Studios IPO Allotment Finalized Today

The allotment process for Recode Studios' initial public offering (IPO) will be finalized on Friday, 8 May. Investors who applied for the IPO can check their allotment status on the registrar's portal, Mudra RTA Ventures Private Ltd. The subscription status on the third bidding day was a staggering 234.64 times, according to chittorgarh.com.

To verify their allotment, investors can follow the guidelines provided by the company. The overall number of shares offered is an important factor in evaluating the IPO allotment status. For applicants who did not receive any shares, the company will initiate the refund process. Successfully allocated shares will be deposited into the individual's demat account.

For individuals who were not allocated shares, the refund procedure will begin on Monday, 11 May. Those who were allocated shares will receive them in their demat accounts on the same day. The Recode Studios IPO listing date is scheduled for Tuesday, 12 May.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

The grey market premium (GMP) for Recode Studios IPO is currently at +42. Considering the upper end of the company's price band and the current premium in the grey market, the estimated listing price of Recode Studios share price is indicated at ₹200 apiece, which is 26.58% higher than the IPO price of ₹158. The IPO GMP has been on an upward trend over the last 10 sessions, indicating a strong debut.

Grey Market Premium Comparison

SessionLowest GMPHighest GMPAverage GMP
1₹11.00₹48.00₹29.50
2₹12.00₹50.00₹31.00
3₹15.00₹52.00₹33.50
4₹18.00₹54.00₹36.00
5₹20.00₹56.00₹38.00
6₹22.00₹58.00₹40.00
7₹24.00₹60.00₹42.00
8₹26.00₹62.00₹44.00
9₹28.00₹64.00₹46.00
10₹30.00₹66.00₹48.00

To check the Recode Studios IPO allotment status on the registrar's portal, Mudra RTA, investors can follow these steps:

Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

  1. Navigate to the website at mudrarta.com/display_ipo_rightissue_allotment.php.
  2. Choose the applicable IPO name from the "Select Company" dropdown list.
  3. Provide either your PAN Number, Application Number, or DPID/Client ID.
  4. Click the "Search" button to check your allotment status.

Alternatively, investors can check their allotment status on the BSE website at https://www.bseindia.com/investors/appli_check.aspx by following these steps:

  1. Navigate to the allotment area on the official BSE website.
  2. Choose 'Equity' from the available options under 'Issue Type.'
  3. From the dropdown menu, select the 'Issue Name' corresponding to the IPO.
  4. Input your application number or PAN.

Investor Takeaway

Investors can check their Recode Studios IPO allotment status in the registrar's portal.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.